The Palliative Prognostic (PaP) Score without Clinical Evaluation Predicts Early Mortality among Advanced NSCLC Patients Treated with Immunotherapy

SIMPLE SUMMARY: The acceptable safety profile of immunotherapy may affect the risk-benefit ratio analysis of treatment prescription near the late stage of life for advanced non-small cell lung cancer patients. The aim of our retrospective study was to describe the clinical characteristics of patient...

Descripción completa

Detalles Bibliográficos
Autores principales: De Giglio, Andrea, Tassinari, Elisa, Zappi, Arianna, Di Federico, Alessandro, Lenzi, Barbara, Sperandi, Francesca, Melotti, Barbara, Gelsomino, Francesco, Maltoni, Marco, Ardizzoni, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739118/
https://www.ncbi.nlm.nih.gov/pubmed/36497326
http://dx.doi.org/10.3390/cancers14235845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9739118/
https://www.ncbi.nlm.nih.gov/pubmed/36497326
http://dx.doi.org/10.3390/cancers14235845

Ejemplares similares